SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-301830
Filing Date
2023-12-22
Accepted
2023-12-22 09:01:59
Documents
13
Period of Report
2023-12-18
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d675636d8k.htm   iXBRL 8-K 27330
2 EX-99.1 d675636dex991.htm EX-99.1 155585
  Complete submission text file 0001193125-23-301830.txt   345237

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA kura-20231218.xsd EX-101.SCH 2866
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE kura-20231218_lab.xml EX-101.LAB 17995
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kura-20231218_pre.xml EX-101.PRE 11272
7 EXTRACTED XBRL INSTANCE DOCUMENT d675636d8k_htm.xml XML 3353
Mailing Address 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130
Business Address 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130 (858) 500-8800
Kura Oncology, Inc. (Filer) CIK: 0001422143 (see all company filings)

IRS No.: 611547851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37620 | Film No.: 231507397
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)